130 related articles for article (PubMed ID: 11358839)
1. Inactivation of p53 sensitizes U87MG glioma cells to 1,3-bis(2-chloroethyl)-1-nitrosourea.
Xu GW; Nutt CL; Zlatescu MC; Keeney M; Chin-Yee I; Cairncross JG
Cancer Res; 2001 May; 61(10):4155-9. PubMed ID: 11358839
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of p53 sensitizes astrocytic glioma cells to BCNU and temozolomide, but not cisplatin.
Xu GW; Mymryk JS; Cairncross JG
J Neurooncol; 2005 Sep; 74(2):141-9. PubMed ID: 16193384
[TBL] [Abstract][Full Text] [Related]
3. Pharmaceutical-mediated inactivation of p53 sensitizes U87MG glioma cells to BCNU and temozolomide.
Xu GW; Mymryk JS; Cairncross JG
Int J Cancer; 2005 Aug; 116(2):187-92. PubMed ID: 15800902
[TBL] [Abstract][Full Text] [Related]
4. Overexpressed WAF1/Cip1 renders glioblastoma cells resistant to chemotherapy agents 1,3-bis(2-chloroethyl)-1-nitrosourea and cisplatin.
Ruan S; Okcu MF; Ren JP; Chiao P; Andreeff M; Levin V; Zhang W
Cancer Res; 1998 Apr; 58(7):1538-43. PubMed ID: 9537261
[TBL] [Abstract][Full Text] [Related]
5. Wild-type p53 renders mouse astrocytes resistant to 1,3-Bis(2-chloroethyl)-1-nitrosourea despite the absence of a p53-dependent cell cycle arrest [corrected].
Nutt CL; Chambers AF; Cairncross JG
Cancer Res; 1996 Jun; 56(12):2748-51. PubMed ID: 8665508
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of WAF1/Cip1 expression by an antisense adenovirus expression vector sensitizes glioblastoma cells to apoptosis induced by chemotherapeutic agents 1,3-bis(2-chloroethyl)-1-nitrosourea and cisplatin.
Ruan S; Okcu MF; Pong RC; Andreeff M; Levin V; Hsieh JT; Zhang W
Clin Cancer Res; 1999 Jan; 5(1):197-202. PubMed ID: 9918219
[TBL] [Abstract][Full Text] [Related]
7. Accumulation of mutant p53(V143A) modulates the growth, clonogenicity, and radiochemosensitivity of malignant glioma cells independent of endogenous p53 status.
Bartussek C; Naumann U; Weller M
Exp Cell Res; 1999 Dec; 253(2):432-9. PubMed ID: 10585266
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene.
Lang FF; Yung WK; Raju U; Libunao F; Terry NH; Tofilon PJ
J Neurosurg; 1998 Jul; 89(1):125-32. PubMed ID: 9647183
[TBL] [Abstract][Full Text] [Related]
9. Identification of a 116 kDa protein able to bind 1,3-bis(2-chloroethyl)-1-nitrosourea-damaged DNA as poly(ADP-ribose) polymerase.
Malapetsa A; Noë AJ; Poirier GG; Desnoyers S; Berger NA; Panasci LC
Mutat Res; 1996 Jan; 362(1):41-50. PubMed ID: 8538647
[TBL] [Abstract][Full Text] [Related]
10. Cells lacking CIP1/WAF1 genes exhibit preferential sensitivity to cisplatin and nitrogen mustard.
Fan S; Chang JK; Smith ML; Duba D; Fornace AJ; O'Connor PM
Oncogene; 1997 May; 14(18):2127-36. PubMed ID: 9174048
[TBL] [Abstract][Full Text] [Related]
11. Human Dkk-1, a gene encoding a Wnt antagonist, responds to DNA damage and its overexpression sensitizes brain tumor cells to apoptosis following alkylation damage of DNA.
Shou J; Ali-Osman F; Multani AS; Pathak S; Fedi P; Srivenugopal KS
Oncogene; 2002 Jan; 21(6):878-89. PubMed ID: 11840333
[TBL] [Abstract][Full Text] [Related]
12. Differential sensitivity of malignant glioma cells to methylating and chloroethylating anticancer drugs: p53 determines the switch by regulating xpc, ddb2, and DNA double-strand breaks.
Batista LF; Roos WP; Christmann M; Menck CF; Kaina B
Cancer Res; 2007 Dec; 67(24):11886-95. PubMed ID: 18089819
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of lipocalin 2 contributes to chemoresistance in glioblastoma cells.
Zheng LT; Lee S; Yin GN; Mori K; Suk K
J Neurochem; 2009 Dec; 111(5):1238-51. PubMed ID: 19860839
[TBL] [Abstract][Full Text] [Related]
14. O(6)-methylguanine-DNA methyltransferase activity, p53 gene status and BCNU resistance in mouse astrocytes.
Nutt CL; Loktionova NA; Pegg AE; Chambers AF; Cairncross JG
Carcinogenesis; 1999 Dec; 20(12):2361-5. PubMed ID: 10590234
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profile induced by BCNU in human glioma cell lines with differential MGMT expression.
Bandres E; Andion E; Escalada A; Honorato B; Catalan V; Cubedo E; Cordeu L; Garcia F; Zarate R; Zabalegui N; Garcia-Foncillas J
J Neurooncol; 2005 Jul; 73(3):189-98. PubMed ID: 15980968
[TBL] [Abstract][Full Text] [Related]
16. Adenovirally-mediated transfer of E2F-1 potentiates chemosensitivity of human glioma cells to temozolomide and BCNU.
Gomez-Manzano C; Lemoine MG; Hu M; He J; Mitlianga P; Liu TJ; Yung AW; Fueyo J; Groves MD
Int J Oncol; 2001 Aug; 19(2):359-65. PubMed ID: 11445852
[TBL] [Abstract][Full Text] [Related]
17. Chemosensitivity of human malignant glioma: modulation by p53 gene transfer.
Trepel M; Groscurth P; Malipiero U; Gulbins E; Dichgans J; Weller M
J Neurooncol; 1998 Aug; 39(1):19-32. PubMed ID: 9760067
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic expression of O(6)-methylguanine DNA methyltransferase-P140K allows intensive treatment of human glioma xenografts with combination O(6)-benzylguanine and 1,3-bis-(2-chloroethyl)-1-nitrosourea.
Kreklau EL; Pollok KE; Bailey BJ; Liu N; Hartwell JR; Williams DA; Erickson LC
Mol Cancer Ther; 2003 Dec; 2(12):1321-9. PubMed ID: 14707273
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of drug resistance genes and chemosensitivity in glial cell lineages correlate with differential response of oligodendrogliomas and astrocytomas to chemotherapy.
Nutt CL; Noble M; Chambers AF; Cairncross JG
Cancer Res; 2000 Sep; 60(17):4812-8. PubMed ID: 10987291
[TBL] [Abstract][Full Text] [Related]
20. Over-representation of specific regions of chromosome 22 in cells from human glioma correlate with resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea.
Hank NC; Shapiro JR; Scheck AC
BMC Cancer; 2006 Jan; 6():2. PubMed ID: 16393339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
